NEW YORK, July 30, 2019 /PRNewswire/ -- Joseph R. Ficalora, President, Chief Executive Officer and a Director of New York Community Bancorp – the 25th largest

STAFFORD, Texas, July 30, 2019 /PRNewswire/ -- Revolution Foods, a company transforming citywide wellness through kid-inspired, chef-crafted school and community meals, has app

SAN FRANCISCO, July 30, 2019 /PRNewswire/ -- Audentes Therapeutics, Inc. (Nasdaq: BOLD), a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases, will host a conference call and webcast to report its second quarter 2019 financial results and provide a corporate update on

PLEASANTON, Calif., July 30, 2019 /PRNewswire/ -- Unchained Labs, the life sciences company that's all about getting biologics researchers the right tool for the job, rolled out its

LOS ALAMOS, N.M., July 30, 2019 /PRNewswire/ -- Trait Biosciences Inc. ("Trait" or the "Company"), a biotechnology leader in the cannabis industry, is pleased to announ

LEXINGTON, Mass., July 30, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the Company will release its second quarter financial results on Tuesday, August 6, 2019, after the close of US markets. Management will ho

CRANFORD, N.J., July 30, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") ("Company") (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, today reported the Company's decision to develop Mino-Wrap as a drug through the Investigational New Drug ("IND") process. The FDA's IND program is the means

TEL AVIV, Israel, July 30, 2019 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today it will release its unaudited financial results for the quarter ended June 30, 2019 on Tuesday, August 6, 2019, before the US marke

BOTHELL, Wash., July 30, 2019 /PRNewswire/ -- BioLife Solutions

LA JOLLA, Calif., July 30, 2019 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of inno